Investment Division Snapshots
For information on the New York Life Insurance and Annuity Corporation CorpExec Accumulator Variable Universal Life (CEAVUL) insurance product, you may view and/or download the product’s Prospectus and Statement of Additional Information.
For information on the Investment Divisions available within a CEAVUL policy, you may view and/or download the Prospectuses for the Investment Divisions. In addition, you may also view and/or download a quarterly Snapshot for each Investment Division below.
Investors are asked to consider the investment objectives, risks, charges and expenses of the investment carefully before investing. The CEVUL VI Prospectus contains this and other information about the Product and the Investment Divisions available within a CEVUL VI policy. The prospectuses for the Investment Divisions contain information on each of the portfolio's investment objective, style, and associated risk. These Investment Divisions are different from publicly available mutual funds that may have similar names, and their respective investment results may vary. You may also request a prospectus by calling (888) 695-4748. Please read the prospectuses carefully before investing.
Variable Universal Life policies involve insurance-related charges and expenses such as mortality and expense risk charges, surrender charges, cost of insurance, administrative charges, and underlying fund expenses.
CEVULVI policies are available in all 51 jurisdictions, are issued by New York Life Insurance and Annuity Corporation (NYLIAC) (A Delaware Corporation), and are distributed by NYLIFE Distributors LLC, Member FINRA/SIPC. Both NYLIAC and NYLIFE Distributors LLC are wholly owned subsidiaries of New York Life Insurance Company, 51 Madison Avenue, New York, NY 10010.
Form Number: 307-43; in Oregon: 307-43.27
You will need Adobe Acrobat Reader to view these documents. You may download the latest version of Adobe Acrobat Reader from the Adobe Free-Download Site.
Last Updated 12/13/12
SMRU 494464 (12/12) (Exp. 12/14)